Roger S. McIntyre, MD, FRCPC
Psychiatry and Pharmacology, University of Toronto, Toronto, ON, Canada · 7 sessions at 3 meetings · 3 upcoming
Topics
Antipsychotic Prescribing (3)GLP-1 & Metabolic Psychiatry (3)Child & Adolescent (2)Depression (2)Ketamine & EsketamineDiverse & Underserved PopulationsNeuroscience & MechanismsDrug Pipeline & Clinical TrialsPsychedelicsSerious Mental Illness
Sessions
NPA 32nd Annual Psychopharmacology Update 2027
- LectureWhat is the Role of Glutamate in Depression?
The glutamate hypothesis of depression and its therapeutic implications, from ketamine to emerging agents.
- LectureUsing GLP-1s in Psychiatry
Where GLP-1 receptor agonists fit in psychiatric practice, from antipsychotic-associated weight gain to emerging behavioral indications.
NEI Fall Congress 2026
- SymposiumEfficacy, Acceptability, and Accessibility and Accessibility of SDA-PAs: Shared Decision Making in the Selection and Sequencing of Treatments for MDD
Applies shared decision-making to selecting and sequencing serotonin-dopamine activity partial agonists among MDD treatment options. Title reproduced exactly as published on the agenda.
- SymposiumPsychedelics
- SymposiumFrom Stigma to Superpower: Reframing Mental Health Disorders Through Creativity and Contribution
Explores reframing mental illness by highlighting creativity and societal contribution of people with psychiatric conditions.
AACAP Annual Meeting 2026
- CourseResearch Institute: Cardiometabolic Connections With Mind, Medication, and Models of Care in Child and Adolescent Psychiatry
Research institute on the two-way links between psychiatric illness and cardiometabolic health in youth — including medication-related weight gain, insulin resistance, and dyslipidemia — and how that science should inform treatment planning.
Antipsychotic PrescribingChild & AdolescentGLP-1 & Metabolic Psychiatry
- LectureGLP-1 Receptor Agonists In Youth with Mental Disorders: Evidence-Based Application and Development/Repurposing as Psychiatric Drugs
Reviews evidence for using GLP-1 receptor agonists in youth with mental disorders and their potential repurposing as psychiatric treatments.
Child & AdolescentGLP-1 & Metabolic PsychiatryDrug Pipeline & Clinical Trials
Presents with
Andrew J. Cutler · Benjamin I. Goldstein · Daphne Korczak · Gail L. Daumit · Judy Luu · Melissa P. DelBello · Paul E. Croarkin · Thomas L. Schwartz
Is this you? Add your photo
Browse the directory
By date
By specialty
- General Psychiatry
- Psychopharmacology
- Child & Adolescent Psychiatry
- Addiction Psychiatry
- Geriatric Psychiatry
- Forensic Psychiatry
- Consultation-Liaison Psychiatry
- Anxiety & Depression
- Neuroscience
- Psychiatric Nursing / PMHNP
- ADHD
- Bipolar Disorders
- Schizophrenia & Psychosis
- Trauma & PTSD
- Women's & Perinatal Mental Health
- Psychotherapy
- Emergency Psychiatry
- Interventional Psychiatry & Neuromodulation
- Psychedelic Medicine
- Suicide Prevention
- OCD & Related Disorders
- Autism Spectrum
- Sleep Medicine
By location
- International
- Midwest US
- Northeast US
- Southern US
- Western US
- California (6)
- Colorado (4)
- San Diego (4)
- Chicago (3)
- Denver (3)
- Florida (3)
- Illinois (3)
- Washington (3)
- Washington, D.C. (3)
- Arizona (2)
- Atlanta (2)
- Boston (2)
- Georgia (2)
- Hawaii (2)
- Massachusetts (2)
- New York (2)
- New Zealand (2)
- Tennessee (2)
- Texas (2)
- Albuquerque (1)
- Asheville (1)
- Auckland (1)
- Austin (1)
- Baltimore (1)
- Brazil (1)
- Canada (1)
- Cape Town (1)
- Christchurch (1)
- Colorado Springs (1)
- Dallas (1)
- Florence (1)
- France (1)
- Glasgow (1)
- Italy (1)
- Kapolei (1)
- Kentucky (1)
- Koloa (Kauai) (1)
- Lake Buena Vista (1)
- Las Vegas (1)
- Louisiana (1)
- Louisville (1)
- Lyon (1)
- Maryland (1)
- Memphis (1)
- Montreal (1)
- Napa (1)
- Nashville (1)
- Nevada (1)
- New Mexico (1)
- New Orleans (1)
- Newport Beach (1)
- North Carolina (1)
- Orlando (1)
- Phoenix (1)
- Reston (1)
- Rio de Janeiro (1)
- Scottsdale (1)
- South Africa (1)
- Tampa (1)
- United Kingdom (1)
- Virginia (1)
By type
By audience
Speakers & topics
Recurring meetings
- All conference series
- AAAP Annual Meeting and Scientific Symposium
- AACAP Annual Meeting
- AADPRT Annual Meeting
- AAGP Annual Meeting
- AAPL Annual Meeting
- AAPP Annual Meeting
- AAS Annual Conference
- ACLP Annual Meeting
- ACNP Annual Meeting
- ADAA Annual Conference
- AGPA Connect
- AMERSA Annual National Conference
- ANPA Annual Meeting
- APA Annual Meeting
- APNA Annual Conference
- APNA Clinical Psychopharmacology Institute
- APSARD Annual Conference
- APsA National Meeting
- ASAM Annual Conference
- ASCP Annual Meeting
- ASKP3 Annual Conference
- Annual International Conference on ADHD
- Annual OCD Conference
- Best Practices for Mood Disorders
- CINP World Congress of Neuropsychopharmacology
- Child & Adolescent Psychopharmacology (MGH Psychiatry Academy)
- ECNP Congress
- European Congress of Psychiatry
- IEPA International Conference on Early Intervention in Mental Health
- INSAR Annual Meeting
- ISBD Annual Conference
- ISPN Annual Conference
- ISTSS Annual Meeting
- International Brain Stimulation Conference
- International Marcé Society Biennial Conference
- MGH Annual Conference on Psychedelics and Psychedelic Medicine
- MGH Annual Psychopharmacology Conference
- MasterPsych Child & Adolescent Psychiatry Conference
- MasterPsych Psychiatry Conference
- Mayo Clinic Psychiatry Clinical Updates
- Medical Psychiatry: Comprehensive Update Conference
- NEI Congress
- NPA National Psychopharmacology Update
- NPACE Napa: Mental Health & Women's Health Conference
- National Update on Behavioral Emergencies (NUBE)
- Postpartum Support International Annual Conference
- Psych Congress
- Psych Congress NP Institute
- Psychedelic Science
- RANZCP Congress
- RCPsych International Congress
- SBSM Annual Meeting (formerly American Psychosomatic Society Annual Meeting)
- SIRS Congress
- SLEEP Annual Meeting (APSS)
- SOBP Annual Meeting
- Substance Use Disorders: A Comprehensive Review and Update
- WFSBP World Congress of Biological Psychiatry
- World Congress of Psychiatry